Neupogen
Generic name: filgrastim [ fil-GRAS-tim ]
Drug class: Colony stimulating factors
What is Neupogen?
Neupogen (filgrastim) is used to decrease the chance of infection in people who have non myeloid cancer (cancer that does not involve the bone marrow) and are receiving chemotherapy medications that may decrease the number of neutrophils (a type of blood cell needed to fight infection).
Neupogen is also used to help increase the number of white blood cells, and decrease the length of time with fever in people with acute myeloid leukemia (AML; a type of cancer of the white blood cells) who are receiving treatment with chemotherapy medications.
Neupogen is also used in people who are undergoing bone marrow transplants and in people who have severe chronic neutropenia (condition in which there are a low number of neutrophils in the blood).
Neupogen is used to prepare the blood for leukapheresis (a treatment in which certain blood cells are removed from the body.
Neupogen is also used to increase the chance of survival in people who have been exposed to harmful amounts of radiation, which can cause severe and life-threatening damage to your bone marrow.
Neupogen belongs to a class of medications called colony-stimulating factors. It works by helping the body make more neutrophils.
Warnings
Neupogen can cause a serious lung problem called acute respiratory distress syndrome (ARDS) and a rare but serious side effect called capillary leak syndrome. Call your doctor or seek emergency medical attention right away if you have fever with shortness of breath or rapid breathing, stuffy or runny nose followed by tiredness, thirst, decreased urination, and sudden swelling or weight gain.
Neupogen can cause your spleen to become enlarged and rupture (tear). Call your doctor right away if you have left-sided upper stomach pain or left shoulder pain.
Before taking this medicine
You should not use Neupogen if you are allergic to filgrastim or other granulocyte colony stimulating factor such as pegfilgrastim, tbo-filgrastim, sargramostim, or eflapegrastim.
Using Neupogen may increase your risk of developing myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) if you have certain medical conditions. Ask your doctor about this risk.
To make sure Neupogen is safe for you, tell your doctor if you have ever had:
-
sickle cell anemia (a hemoglobin blood cell disorder);
-
latex allergy;
-
radiation treatment; or
-
kidney disease.
It is not known if filgrastim will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.
Ask a doctor if it is safe to breastfeed while using this medicine.
How should I use Neupogen?
Use Neupogen exactly as prescribed by your doctor. Follow all directions on your prescription label and read all medication guides or instruction sheets. Your doctor may occasionally change your dose.
Neupogen can be given by intravenous (IV) infusion or injected under your skin (subcutaneous injection). A healthcare provider may teach you or your caregiver how to properly use this medication at home.
Doses are based on weight. Your dose may change if you gain or lose weight.
Your healthcare provider will show you where to inject Neupogen. Do not inject into the same place two times in a row.
Do not inject into areas where the skin is tender, bruised, red, or hard. Avoid injecting into skin that has scars or stretch marks.
Do not change your dose or stop using a medicine without your doctor's advice.
Your dose needs may change if you switch to a different brand, strength, or form of this medicine. Avoid medication errors by using only the medicine your doctor prescribes. Do not switch brand forms without your doctor's advice.
Ask your doctor or pharmacist if you don't understand how to use an injection.
Prepare an injection only when you are ready to give it. Call your pharmacist if the medicine looks cloudy, has changed colors or has particles in it.
Do not reuse a needle or syringe. Place them in a puncture-proof "sharps" container and dispose of it following state or local laws. Keep out of the reach of children and pets.
If you are receiving Neupogen because you are also receiving chemotherapy, your Neupogen dose should be injected at least 24 hours before or 24 hours after your dose of chemotherapy.
Your blood will need to be tested often. You may need medical tests to help determine your Neupogen dosage or how long you should use this medicine.
This medicine can affect the results of certain medical tests. Tell any doctor who treats you that you are using Neupogen.
Store Neupogen in the original container in a refrigerator, away from light. Do not freeze and do not shake.
Do not warm the medicine with hot water, sunlight, or a microwave.
Take Neupogen out of the refrigerator and let it reach room temperature for 30 minutes before using. Do not leave the medicine out for longer than 24 hours.
Throw away a prefilled syringe or vial (bottle) after one use, even if there is still medicine left inside.
Related/similar drugs
fluconazole, Diflucan, cisplatin, filgrastim, Zarxio, Neulasta, pegfilgrastim, Fulphila, Udenyca, Nivestym
What happens if I miss a dose?
Call your doctor for instructions if you miss a dose.
What happens if I overdose?
Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.
What should I avoid while using Neupogen?
Avoid being near people who are sick or have infections. Tell your doctor at once if you develop signs of infection.
Neupogen side effects
Get emergency medical help if you have signs of an allergic reaction to Neupogen: hives, sweating, rash, dizziness, fast heart rate, wheezing, difficult breathing, swelling of your face, lips, tongue, or throat.
Neupogen can cause a serious lung problem called acute respiratory distress syndrome (ARDS) and a rare but serious side effect called capillary leak syndrome. Call your doctor or seek emergency medical attention right away if you have fever with shortness of breath or rapid breathing, stuffy or runny nose followed by tiredness, thirst, decreased urination, and sudden swelling or weight gain.
Neupogen can cause your spleen to become enlarged, and it could rupture (tear). Call your doctor right away if you have left-sided upper stomach pain or left shoulder pain.
Some side effects may occur during the injection. Tell your medical caregiver if you feel dizzy, nauseated, light-headed, itchy, sweaty, or have a headache, chest tightness, back pain, trouble breathing, or swelling in your face.
Neupogen may cause serious side effects. Call your doctor at once if you have:
-
easy bruising, unusual bleeding, purple or red spots of your skin or under your skin;
-
fever, tiredness, stomach pain, back pain;
-
signs of sickle cell anemia crisis - pain or difficulty breathing;
-
inflammation of your blood vessels - numbness or tingling, skin rash, fever, headache, body aches, night sweats, weight loss, feeling or weak or tired; or
-
kidney problems - swelling, urinating less, feeling tired or short of breath.
Common Neupogen side effects may include:
-
fever, pain, cough, trouble breathing;
-
nosebleeds;
-
anemia (low red blood cells);
-
bone pain;
-
headache;
-
numbness; or
-
rash, hair loss.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What other drugs will affect Neupogen?
Do not use Neupogen within 24 hours before or after you receive chemotherapy, or within 24 hours after a bone marrow transplant.
Other drugs may interact with filgrastim, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all other medicines you use.
Ingredients
Active ingredient: filgrastim
Inactive ingredient: acetate, polysorbate 80, sodium, sorbitol, and water for Injection.
Manufacturer
Amgen Inc. One Amgen Center Drive, Thousand Oaks, California 91320, USA.
.Neupogen Biosimilars
Biosimilar and interchangeable products are biological products that are highly similar to and have no clinically meaningful differences from the reference product.
Reference products
These are biological products that have already been approved by the FDA, against which biosimilar products are compared. There are 2 for Neupogen.
Granix (tbo-filgrastim) - UAB Teva Baltics
Formulation type | Strength |
---|---|
Pre-Filled Syringe | 300 mcg/0.5 mL |
Pre-Filled Syringe | 480 mcg/0.8 mL |
Single-Dose Vial | 300 mcg/1 mL |
Single-Dose Vial | 480 mcg/1.6 mL |
View Granix information in detail.
Neupogen (filgrastim) - Amgen Inc.
Formulation type | Strength |
---|---|
Pre-Filled Syringe | 300 mcg/0.5 mL |
Pre-Filled Syringe | 480 mcg/0.8 mL |
Single-Dose Vial | 300 mcg/mL |
Single-Dose Vial | 480 mcg/1.6 mL |
Neupogen biosimilar products
Biosimilar products can only be dispensed in place of the reference product if the healthcare provider specifically prescribes the biosimilar product by name.
Pharmacy laws for biosimilar prescribing may vary by state
Nivestym (filgrastim-aafi) - Hospira Inc., a Pfizer Company
Formulation type | Strength |
---|---|
Pre-Filled Syringe | 300 mcg/0.5 mL |
Pre-Filled Syringe | 480 mcg/0.8 mL |
Single-Dose Vial | 300 mcg/mL |
Single-Dose Vial | 480 mcg/1.6 mL |
View Nivestym information in detail.
Nypozi (filgrastim-txid) - Tanvex BioPharma USA, Inc.
Formulation type | Strength |
---|---|
Pre-Filled Syringe | 300 mcg/0.5 mL |
Pre-Filled Syringe | 480 mcg/0.8 mL |
View Nypozi information in detail.
Releuko (filgrastim-ayow) - Kashiv BioSciences, LLC
Formulation type | Strength |
---|---|
Pre-Filled Syringe | 300 mcg/0.5 mL |
Pre-Filled Syringe | 480 mcg/0.8 mL |
Single-Dose Vial | 300 mcg/mL |
Single-Dose Vial | 480 mcg/1.6 mL |
View Releuko information in detail.
Zarxio (filgrastim-sndz) - Sandoz Inc.
Formulation type | Strength |
---|---|
Pre-Filled Syringe | 300 mcg/0.5 mL |
Pre-Filled Syringe | 480 mcg/0.8 mL |
Single-Dose Vial | 300 mcg/0.5 mL Discontinued |
Single-Dose Vial | 480 mcg/0.8 mL Discontinued |
View Zarxio information in detail.
Popular FAQ
What are biosimilar drugs and how do they compare to biologics?
A biosimilar is a biological product that is similar to a reference biologic (usually the originally approved product) and for which there are no clinically meaningful differences in terms of safety, purity, and potency. One example is Amjevita (adalimumab-atto), the first biosimilar approved for Humira (adalimumab) in 2016. Continue reading
More FAQ
- What biosimilars have been approved in the United States?
- What is the difference between Nivestym and Neupogen?
References
More about Neupogen (filgrastim)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (3)
- Side effects
- Dosage information
- During pregnancy
- Drug class: colony stimulating factors
- Breastfeeding
Patient resources
Other brands
Zarxio, Nivestym, Releuko, Nypozi
Professional resources
Other brands
Related treatment guides
Further information
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use Neupogen only for the indication prescribed.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Copyright 1996-2024 Cerner Multum, Inc. Version: 11.01.